Posters
Pharmacology (PharmacoKinetics, -Dynamics, -Genomics)
October 22, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Implementing Universal Pharmacogenomics Testing in Patients with ESKD at a Veterans Affairs (VA) Dialysis Center
Quality Improvement Intervention to Reduce Medication Discrepancies in a CKD Population
Evaluating Clinical Decision Support Tools for Renally Adjusted Medication Prescribing
Renal Impairment Does Not Have a Clinically Meaningful Effect on the Pharmacokinetics of the Oral PCSK9 Inhibitor Enlicitide
Comparative Analysis of Potential Toxicity from Long-Term Colchicine Use in Patients with ESKD on Hemodialysis vs. CKD G3-G5: An Ambispective Noninferiority Study Using Inverse Probability Weighting (IPW) Confounder Summary Score
Pharmacokinetics and Potential Toxicity of Long-Term Colchicine Use in Patients on Hemodialysis: A Prospective Observational Study
Pharmacokinetics of Immune Checkpoint Inhibitors Are Best Recapitulated in Human Immune System Mice
A Phase 1 Mass Balance Study of 14C-AND017, a Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in Healthy Male Participants
Model-Based Assessment of Clinical Responses to A Proliferation-Inducing Ligand (APRIL) Blockade Informing Development of the Anti-APRIL Monoclonal Antibody JADE101 in IgAN
CLYM116, a Novel "Sweeper" Anti-A Proliferation-Inducing Ligand Monoclonal Antibody in Development for IgAN: Phase 1 Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) Results in Healthy Volunteers
Nephrocast-V2: A Pharmacokinetics-Informed Recurrent Deep Learning Model for Vancomycin Therapeutic Drug Monitoring in Critically Ill Patients
Integrating Pharmacogenomics into Nephrology: Optimizing Drug Therapy and Reducing Adverse Drug Reactions in Kidney Disease and Transplant Care
Optimizing Vancomycin Dosing in Haemodialysis: Effect of a Revised Weight-Based Protocol in a Singapore Hospital
Determinants of Vancomycin Clearance During CRRT: A Longitudinal Analysis of Patient- and Machine-Level Factors
Population Pharmacokinetics of Teicoplanin in Critically Ill Patients Undergoing CKRT: Effect of Residual Kidney Function and Effluent Flow Rate on Drug Clearance
Dosing of Anti-Infective Drugs During Therapeutic Plasma Exchange in Sepsis: A Narrative Review of Considerations for Practical Application
Kidney Transporter-Informed Physiologically Based Pharmacokinetic Modeling: A Novel Approach to Characterize Metformin Disposition in Critically Ill Patients with Sepsis
Pantoprazole-Associated Increases in Plasma Creatinine Are Due to Inhibition of Tubular Secretion and Not Kidney Injury
Characterizing the Role of Tubular Albumin Endocytosis in Renal Per- and Polyfluoroalkyl Substances Reabsorption: A Translational Approach
Hierarchical Serum, Urinary, and Tissue Proteomic Responses in Salt-Induced Kidney Injury and Differential Actions of the Mineralocorticoid Receptor (MR) Antagonist Esaxerenone
Long-Term Treatment with an ACE Inhibitor and an SGLT2 Inhibitor Causes Concentric Hypertrophy of Glomerular Arterioles
Src-Dependent Caveolae-Mediated Albumin Endocytosis Through Glomerular Endothelial and Epithelial Cells Drives Albuminuria and Is Suppressed by Genistein in Diabetic Nephropathy
Gadolinium-Rich Nanoparticle Biogenesis After MultiHance Exposure
Pharmacokinetic/Toxicodynamic Model of Platinum Kidney Injury Using Urinary Calbindin and Beta-2-Microglobulin as Biomarkers
Isovitexin, a Naturally Occurring Molecule, Alleviates Kidney Tubulointerstitial Fibrosis by Mediating Epithelial-to-Mesenchymal Transition, Inflammation, Oxidative Stress, and Ferroptotic Pathways
Asiaticoside Directly Binds CD40 with Species-Selective Regulation to Attenuate Renal Fibrosis
ErbB Ligand Selectivity and Preclinical Pharmacokinetics of DTR8, a Heparin-Binding Epidermal Growth Factor-Like Growth Factor (HB-EGF) Antagonist for Crescentic Glomerulonephritis
Tri-Omic Analysis Identifies a Glomerular-Specific Epigenetic Vulnerability in Hydralazine-Induced Vasculitis
Kidney Outcomes Among Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor vs. Gut-Selective Biologic Therapy: A Propensity-Matched TriNetX Analysis
Real-World Safety Profile of RNA Interference Therapies in Primary Hyperoxaluria: A Pharmacovigilance Study
GLP-1 Receptor Agonist Use and Stone Recurrence in Uric Acid Nephrolithiasis
Two Cases of Different Crystal Nephropathy Associated with Two Different GLP-1 Receptor Agonists
When "Safe" Isn't Safe: Clinically Significant Systemic Vancomycin Exposure from Oral Therapy in a High-Risk Patient
Sustained Reversal of Hyperaldosteronism After Aldosterone Synthase Inhibitor Exposure in a Patient with Primary Aldosteronism and CKD: Implications for Targeted Adrenal Therapy
When the Treatment Becomes the Disease: Rituximab-Induced Crohn Disease in PR3+ ANCA-Associated Vasculitis
Chronic Diarrhea in an Older Patient with CKD: A Case for Caution
Not All Diarrhea on Mycophenolate Is Mycophenolate: Losartan-Associated Enteropathy Mimicking Immunosuppression Toxicity
Thalidomide as Salvage Therapy for Refractory Gastrointestinal Angiodysplasia-Induced Bleeding in ESKD
Ethacrynic Acid-Induced Severe Thrombocytopenia in Advanced CKD
Discovery of a Novel IL1R1 Pharmacogenomic Interaction Shaping Frailty in Kidney Transplant Recipients